Cargando…

Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1

Detalles Bibliográficos
Autores principales: Ni, Wen, Zhang, Yuqin, Zhan, Zetao, Ye, Feng, Liang, Yonghao, Huang, Jing, Chen, Keli, Chen, Longhua, Ding, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169315/
https://www.ncbi.nlm.nih.gov/pubmed/37158936
http://dx.doi.org/10.1186/s13045-023-01447-z
_version_ 1785039029437202432
author Ni, Wen
Zhang, Yuqin
Zhan, Zetao
Ye, Feng
Liang, Yonghao
Huang, Jing
Chen, Keli
Chen, Longhua
Ding, Yi
author_facet Ni, Wen
Zhang, Yuqin
Zhan, Zetao
Ye, Feng
Liang, Yonghao
Huang, Jing
Chen, Keli
Chen, Longhua
Ding, Yi
author_sort Ni, Wen
collection PubMed
description
format Online
Article
Text
id pubmed-10169315
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101693152023-05-11 Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Ni, Wen Zhang, Yuqin Zhan, Zetao Ye, Feng Liang, Yonghao Huang, Jing Chen, Keli Chen, Longhua Ding, Yi J Hematol Oncol Correction BioMed Central 2023-05-08 /pmc/articles/PMC10169315/ /pubmed/37158936 http://dx.doi.org/10.1186/s13045-023-01447-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Ni, Wen
Zhang, Yuqin
Zhan, Zetao
Ye, Feng
Liang, Yonghao
Huang, Jing
Chen, Keli
Chen, Longhua
Ding, Yi
Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
title Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
title_full Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
title_fullStr Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
title_full_unstemmed Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
title_short Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1
title_sort correction: a novel lncrna uc.134 represses hepatocellular carcinoma progression by inhibiting cul4a-mediated ubiquitination of lats1
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169315/
https://www.ncbi.nlm.nih.gov/pubmed/37158936
http://dx.doi.org/10.1186/s13045-023-01447-z
work_keys_str_mv AT niwen correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT zhangyuqin correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT zhanzetao correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT yefeng correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT liangyonghao correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT huangjing correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT chenkeli correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT chenlonghua correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1
AT dingyi correctionanovellncrnauc134represseshepatocellularcarcinomaprogressionbyinhibitingcul4amediatedubiquitinationoflats1